Cancerify Logo
Log inSign up
Back to clinical trials
RecruitingInterventional

The Care Tracker Study: Using Patient-Reported Data to Address Racial Disparities in Cancer Treatment Delay

NCT ID: NCT06096623Sponsor: UNC Lineberger Comprehensive Cancer CenterLast updated: 2026-02-05

Summary

This study assesses the feasibility and acceptability of a brief electronic patient-reported outcome (ePRO) tool that allows patients to self-identify impending delays. The risk of treatment delays according to tumor type and race will be measured by both ePRO and electronic health record (EHR) tools. Data from this study and the association of social determinants of health could be useful to flag patients at risk of delay and due timely intervention for modifiable treatment barriers. The prediction of the risk of treatment delay will be helpful to design another study using electronic tracking systems to prevent cancer treatment delays. The long-term goal of this research is to alert care teams when patients may be at risk of treatment days and to help patients get treatment faster. It was planned to enroll a total of 240 subjects with newly diagnosed cancer. Sixty colorectal and 180 breast cancer patients will be included.

Arms & interventions

  • BehavioralWeekly Survey

    Subjects will respond to Electronic patient-reported outcome (ePRO) every week for 8 weeks.

Outcome measures

Primary

  • Feasibility of Electronic patient-reported outcome (ePRO)

    Feasibility of Electronic patient-reported outcome (ePRO) will be assessed as the proportion of subjects who responded to at least 4 out of offered 8 weekly ePRO.

    Time frame: Baseline to 56 days post-enrollment

  • Electronic patient-reported outcome (ePRO) confirming treatment initiation

    Electronic patient-reported outcome (ePRO) confirming treatment initiation will be measured as the proportion of subjects who responded to at least one of the offered weekly ePRO) surveys.

    Time frame: Baseline to 56 days post-enrollment

Secondary

  • Delayed Treatment

    Time frame: Baseline to 56 days post-enrollment

  • Time to ePRO-reported treatment

    Time frame: Baseline to 56 days post-enrollment

  • Proportion of treatment delay

    Time frame: Baseline to 56 days post-enrollment

  • Time to treatment in days

    Time frame: Baseline to 180 days post-enrollment

Eligibility criteria

Sex: AllAge: 18 Years and olderHealthy volunteers: No
Inclusion Criteria: In order to participate in this study a subject must meet all of the eligibility criteria outlined below. 1. Male and female patients of age \>18 years. 2. Pathologic diagnosis of breasts or colorectal cancer within 6 weeks (42 days) prior to the enrollment date. 3. Have not yet initiated cancer treatment on the date of enrollment. 4. Indicate intent to receive cancer treatment at the University of North Carolina. Exclusion Criteria: 1. Patient unwilling or unable to receive electronic survey links via email or text link on a mobile device, tablet, laptop, or desktop computer. 2. Patient unwilling or unable to provide verbal or signed consent to participate. 3. Patient cannot read and speak English. 4. Patients who do not have email access or a smartphone are able to receive Short Message/Messaging Service (SMS) text messages.

Study locations (1)

University of North Carolina

Chapel Hill, North Carolina, 27599

Recruiting
Erin Laurie-Zehr, MA · Contact
919-445-6199erin_laurie@med.unc.edu
Katie Reeder-Hayes, MD · Principal Investigator